166 related articles for article (PubMed ID: 16185938)
1. Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent.
Kahles T; Foerch C; Sitzer M; Schroeter M; Steinmetz H; Rami A; Neumann-Haefelin T
Vascul Pharmacol; 2005 Oct; 43(4):254-9. PubMed ID: 16185938
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
Kelly MA; Shuaib A; Todd KG
Exp Neurol; 2006 Jul; 200(1):38-49. PubMed ID: 16624294
[TBL] [Abstract][Full Text] [Related]
3. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
4. rt-PA causes a dose-dependent increase in the extravasation of cellular and non-cellular blood elements after focal cerebral ischemia.
Burggraf D; Martens HK; Dichgans M; Hamann GF
Brain Res; 2007 Aug; 1164():55-62. PubMed ID: 17644075
[TBL] [Abstract][Full Text] [Related]
5. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
[TBL] [Abstract][Full Text] [Related]
6. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice.
Chen HY; Chen TY; Lee MY; Chen ST; Hsu YS; Kuo YL; Chang GL; Wu TS; Lee EJ
J Pineal Res; 2006 Sep; 41(2):175-82. PubMed ID: 16879324
[TBL] [Abstract][Full Text] [Related]
7. 17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats.
Liu R; Wen Y; Perez E; Wang X; Day AL; Simpkins JW; Yang SH
Brain Res; 2005 Oct; 1060(1-2):55-61. PubMed ID: 16212944
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y
Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526
[TBL] [Abstract][Full Text] [Related]
9. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
Vakili A; Hosseinzadeh F; Sadogh T
Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
[TBL] [Abstract][Full Text] [Related]
10. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y
Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats.
Aoki T; Sumii T; Mori T; Wang X; Lo EH
Stroke; 2002 Nov; 33(11):2711-7. PubMed ID: 12411666
[TBL] [Abstract][Full Text] [Related]
12. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
13. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.
Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S
Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717
[TBL] [Abstract][Full Text] [Related]
14. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
[TBL] [Abstract][Full Text] [Related]
15. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia.
Gartshore G; Patterson J; Macrae IM
Exp Neurol; 1997 Oct; 147(2):353-60. PubMed ID: 9344560
[TBL] [Abstract][Full Text] [Related]
16. dl-3-n-butylphthalide attenuates reperfusion-induced blood-brain barrier damage after focal cerebral ischemia in rats.
Chong ZZ; Feng YP
Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):696-700. PubMed ID: 10678100
[TBL] [Abstract][Full Text] [Related]
17. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
Copin JC; Gasche Y
Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.
Liu XS; Zhang ZG; Zhang L; Morris DC; Kapke A; Lu M; Chopp M
J Cereb Blood Flow Metab; 2006 Jun; 26(6):787-96. PubMed ID: 16177809
[TBL] [Abstract][Full Text] [Related]
19. Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats.
Turner RJ; Vink R
Neuroscience; 2012 Sep; 220():1-10. PubMed ID: 22750240
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M
Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
